B. Berent-Maoz
Molecular Biology · 2013–2016
A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 52 citations into it
- Immunology — 46 citations into it
Whom B. Berent-Maoz trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from B. Berent-Maoz's perspective
Ordered by how strongly the researchers B. Berent-Maoz trusts endorse each paper. Same corpus, a different order for every researcher.
- Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. (Mechanisms of Ageing and Development)
- Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion (Nature Cell Biology)
- Dnmt3a is essential for hematopoietic stem cell differentiation (Nature Genetics)
- Ink4a/Arf expression is a biomarker of aging. (Journal of Clinical Investigation)
- VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. (Genome Research)
- Age-Associated Characteristics of Murine Hematopoietic Stem Cells (Journal of Experimental Medicine)
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma (New England Journal of Medicine)
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients (Nature)
- The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
Their papers
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma (2016) — 3,046 citations
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma (2016) — 2,767 citations
- Primary resistance to PD-1 blockade mediated by JAK1/2 mutations (2016) — 1,167 citations
- Causes, consequences, and reversal of immune system aging. (2013) — 722 citations